The transaction also brought a $200 million investment for Sema4 from life science investors including Pfizer, which can help the combined company's goal of translating insights from genomics data and analytics into making precision medicine a standard of care.
The future of medicine lies in treatments that are tailored to individual patients’ needs. This approach directs the appropriate care to each patient and maximizes healthcare outcomes. Today, “precision” medicine is a growing movement that utilizes information about an individual’s biology to personalize healthcare decision making. Advanced medical imaging has emerged as an important complement […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.